Bernstein Harold
SEC insider (Form 3/4/5 filer). CIK 0002050172. President, R&D & CMO at Maze Therapeutics, Inc. (MAZE). 48 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Bernstein Harold has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Officer, President, R&D & CMO
Bernstein Harold
CIK: 0002050172
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Maze Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (48 total)
- Oct 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect16.1K shares at avg. $10.42$168K - Oct 1, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect16.1K shares at avg. $26.93$435K - Sep 4, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect9.7K shares at avg. $26.22$255K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect5.1K shares at avg. $26.01$133K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect59 shares at avg. $25.78$2K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect4.5K shares at avg. $26.38$118K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect625 shares at avg. $27.12$17K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect16.1K shares at avg. $26.36$426K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect20K shares- - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect16.1K shares at avg. $10.42$168K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 16,141 | $10.42 | $168,189 | Direct |
| Oct 1, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 16,141 | $26.93 | $434,743 | Direct |
| Sep 4, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 9,705 | $26.22 | $254,502 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 5,130 | $26.01 | $133,448 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 59 | $25.78 | $1,521 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 4,481 | $26.38 | $118,191 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 625 | $27.12 | $16,951 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 16,141 | $26.36 | $425,512 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 20,000 | - | $0 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 16,141 | $10.42 | $168,189 | Direct |
1-10 of 48 transactions